Shohei Hashiguchi
Takeda Pharmaceutical Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shohei Hashiguchi.
Journal of The Chemical Society-perkin Transactions 1 | 1988
Shohei Hashiguchi; Hideaki Natsugari; Michihiko Ochiai
γ-Lactamanalogues of carbapenems{(7S)-7-acylamino-2-carboxy-3-(substituted-thio)-1-azabicyclo[3.3.0]oct-2-en-8-ones}(2) were synthesized starting from L-aspartic acid. Condensation of the oxo ester (4) with 2, 4-dimethoxybenzylamine followed by cyclization gave preferentially the E-γ-lactam (6), which was transformed into the 3, 5-cis-5-carboxymethyl-γ-lactam cis-(9)via stereoselective catalytic reduction. The major product cis-(9) and its trans-isomer were converted into compound (2)via a carbene insertion reaction. The antibacterial activity of the trans-acetamidoethylthio derivative (23) slightly exceeded that of the corresponding cis-derivative (17).
Journal of The Chemical Society-perkin Transactions 1 | 1991
Shohei Hashiguchi; Akira Kawada; Hideaki Natsugari
Bakers yeast reduction of methyl (4S)-4-(tert-butoxycarbonylamino)-3-oxopentanoate 6 stereoselectively afforded methyl (3R,4S)-erythro-4-Boc-amino-3-hydroxypentanoate 7, which was converted into the erythro keto δ-lactone 3a in three steps. The threo keto δ-lactones 3b–c were diastereoselectively prepared by cyclocondensation of N-Boc D- and L-alaninal 4 with 1 -methoxy-1, 3-bis(trimethylsiloxy)buta-1,3-diene 9 in the presence of a catalytic amount of tin(II) chloride. Recluctive amination of the keto lactones 3 using 5% platinum on carbon as catalyst in an acidic medium stereoselectively afforded the N-protected 3,6-diamino-5-hydroxyheptanoic acid lactones 1 with 3,5-anti stereochemistry. These were transformed into the enantiomerically pure sperabillin 17 and negamycin 20 derivatives in good yields. The configuration of sperabillin B and D was determined to be (3R,5R,6R) by comparison of the synthetic amino lactone 1e with a degradation product of sperabillin B and by the successful transformation of the synthetic amino lactone 1b into sperabillin D.
Journal of the American Chemical Society | 1995
Shohei Hashiguchi; Akio Fujii; Jun Takehara; Takao Ikariya; Ryoji Noyori
Journal of the American Chemical Society | 1995
Takeshi Ohkuma; Hirohito Ooka; Shohei Hashiguchi; Takao Ikariya; Ryoji Noyori
Bioorganic & Medicinal Chemistry | 2003
Tomoyasu Ishikawa; Nobuyuki Matsunaga; Hiroyuki Tawada; Noritaka Kuroda; Yutaka Nakayama; Yukio Ishibashi; Mitsumi Tomimoto; Yukihiro Ikeda; Yoshihiko Tagawa; Yuji Iizawa; Kenji Okonogi; Shohei Hashiguchi; Akio Miyake
Journal of Infection and Chemotherapy | 2004
Yuji Iizawa; Junko Nagai; Tomoyasu Ishikawa; Shohei Hashiguchi; Masafumi Nakao; Akio Miyake; Kenji Okonogi
Archive | 2000
Shinichi Imamura; Shohei Hashiguchi; Taeko Hattori; Osamu Nishimura; Naoyuki Kanzaki; Masanori Baba; Yoshihiro Sugihara
Archive | 1996
Takao Ikariya; Shohei Hashiguchi; Jun Takehara; Nobuyuki Uematsu; Kazuhiko Matsumura; Ryoji Noyori; Akio Fujii
Bioorganic & Medicinal Chemistry | 2005
Shinichi Imamura; Youichi Nishikawa; Takashi Ichikawa; Taeko Hattori; Yoshihiro Matsushita; Shohei Hashiguchi; Naoyuki Kanzaki; Yuji Iizawa; Masanori Baba; Yoshihiro Sugihara
Chemical & Pharmaceutical Bulletin | 2004
Shinichi Imamura; Yuji Ishihara; Taeko Hattori; Osamu Kurasawa; Yoshihiro Matsushita; Yoshihiro Sugihara; Naoyuki Kanzaki; Yuji Iizawa; Masanori Baba; Shohei Hashiguchi